CCND1 and prostate carcinoma: Conversely, downstream factors of the Wnt pathway, including β-catenin, TCF/LEF transcription factors, and target genes like c-myc and cyclin D1, participate in malignant phenotypes such as cell proliferation, anti-apoptosis, angiogenesis, and metastasis in prostate cancer [25,26].